Chemistry

Photo

Syensqo Announces CEO Transition

Syensqo has announced that Ilham Kadri will step down as CEO on January 1, 2026, with Mike Radossich, current President of Performance & Care, set to assume the role and lead the company into its next growth phase.

665 more articles

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.